Psoriasis and anxiety are chronic conditions with significant morbidity and there is evidence
that they may exacerbate one another. There is little data on the prevalence of anxiety in …

… Gulliver has received honoraria for participation in advisory boards for AbbVie, Amgen,
Bio-K, and Janssen and for participation in speaker engagements and consultative meetings for …

Background Twenty to fifty percent of patients with psoriasis have depressive symptoms.
Objective To describe the effects of biologics (tumour necrosis factor inhibitors [ TNF i] or …

Background: In previous phase II studies, alefacept significantly improved psoriasis and was
well tolerated. The clinical response to alefacept was durable. Objective: Our purpose was …

Psoriasis is associated with significant physical, psychological, social and economic burden,
the cumulative effect of which may result in failure to achieve ‘full life potential’ in some …

Background Hidradenitis suppurativa (HS) is a severe chronic inflammatory follicular disease
characterized by nodules and abscesses affecting apocrine gland‐bearing regions. HS is …

OBJECTIVE: This randomized, double‐blind, multi‐centre study compared the long‐term safety
and tolerability of pimecrolimus cream 1% and topical corticosteroids (TCS) in 658 adults …

Background: Anti-CD11a (hu1124) is a humanized monoclonal antibody directed against
the CD11a subunit of LFA-1. This study investigated whether treatment with anti-CD11a …

Psoriasis is a chronic inflammatory disorder with significant physical and psychological
sequelae. The majority of individuals experience disease onset in early adult life – for women …

Background: Smoking has been associated with psoriasis prevalence and severity.
Objective: To evaluate prevalence of smoking in patients with psoriasis and to examine the …